GE Healthcare
 
GE Healthcare Life Sciences Part of GE Healthcare
Location: Home > BioProcess™ > Target Molecules > Plasma Proteins > Factor VIII
BioProcess™
Target Molecules
Antibodies
Plasma Proteins
Albumin
Factor VIII
IgG
Recombinant Proteins
Vaccines

Factor VIII

The purification scheme shown has been developed for purification of Factor VIII from fresh frozen plasma.

The method gives high yield of pure Factor VIII secure against virus transmission with specific activity of 300 IU / mg before formulation with albumin. The recovery of Factor VIII is 200 IU / L plasma. Two independent virus inativation steps are used in the method. For virus clearance issues see our BioSafety section under Products.

Factor VIII produced with this process has been approved for clinical use and sale in Denmark and Holland under the trade name Nordiate.*

* Manufactured and sold by HemaSure A/S Denmark.

Read more about how to purify Albumin and IgG.